Related references
Note: Only part of the references are listed.Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment
Mubin Tarannum et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
Jakub Szymczyk et al.
CANCERS (2021)
Role of FGFR2c and Its PKCε Downstream Signaling in the Control of EMT and Autophagy in Pancreatic Ductal Adenocarcinoma Cells
Danilo Ranieri et al.
CANCERS (2021)
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
Parniyan Maneshi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Sophie Liot et al.
FRONTIERS IN IMMUNOLOGY (2021)
Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
Edward P. Carter et al.
CELLS (2021)
Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment
Darya Javadrashid et al.
BIOMEDICINES (2021)
Expression of the E5 Oncoprotein of HPV16 Impacts on the Molecular Profiles of EMT-Related and Differentiation Genes in Ectocervical Low-Grade Lesions
Danilo Ranieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Early detection of pancreatic cancer using DNA-based molecular approaches
Aatur D. Singhi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma
Lesley Castillo et al.
ONCOGENE (2020)
Role of PKCε in the epithelial-mesenchymal transition induced by FGFR2 isoform switch
Danilo Ranieri et al.
CELL COMMUNICATION AND SIGNALING (2020)
Acidic fibroblast growth factor underlies microenvironmental regulation of MYC in pancreatic cancer
Sohinee Bhattacharyya et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Novel therapeutic approaches for pancreatic cancer by combined targeting of RAF→MEK→ERK signaling and autophagy survival response
Faustino Mollinedo et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Expression of the FGFR2c mesenchymal splicing variant in human keratinocytes inhibits differentiation and promotes invasion
Danilo Ranieri et al.
MOLECULAR CARCINOGENESIS (2018)
Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion
Adelaide I. J. Young et al.
CELL ADHESION & MIGRATION (2018)
Role of fibroblast growth factor receptor-2 splicing in normal and cancer cells
Toshiyuki Ishiwata
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma
Ayano Kabashima et al.
JOURNAL OF HEPATOLOGY (2018)
Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression
Noah Isakov
SEMINARS IN CANCER BIOLOGY (2018)
Survival of pancreatic cancer cells lacking KRAS function
Mandar Deepak Muzumdar et al.
NATURE COMMUNICATIONS (2017)
Protein kinase C-eta regulates Mcl-1 level via ERK1
Deepanwita Pal et al.
CELLULAR SIGNALLING (2017)
Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
Danilo Ranieri et al.
ONCOTARGET (2016)
Phosphorylated Bcl-2 and Mcl-1 as prognostic markers in small cell lung cancer
Oncotarget (2016)
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib
Adelaide I. J. Young et al.
BREAST CANCER RESEARCH (2016)
Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer
C. M. Goodwin et al.
CELL DEATH AND DIFFERENTIATION (2015)
Targeting FGFR Signaling in Cancer
Mehdi Touat et al.
CLINICAL CANCER RESEARCH (2015)
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2015)
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
J. D. Leverson et al.
CELL DEATH & DISEASE (2015)
HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition
Danilo Ranieri et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Expression of Ser729 phosphorylated PKCepsilon in experimental crescentic glomerulonephritis: an immunohistochemical study
V. N. Karavana et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2014)
A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo
Fardokht Abulwerdi et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases
J. Ueda et al.
ONCOGENE (2014)
Rapid Induction of Apoptosis by PI3K Inhibitors Is Dependent upon Their Transient Inhibition of RAS-ERK Signaling
Marie Will et al.
CANCER DISCOVERY (2014)
Protein Kinase C-epsilon Promotes EMT in Breast Cancer
Kirti Jain et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2014)
Enhanced Expression of Fibroblast Growth Factor Receptor 2 IIIc Promotes Human Pancreatic Cancer Cell Proliferation
Toshiyuki Ishiwata et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
PKCε Promotes Oncogenic Functions of ATF2 in the Nucleus while Blocking Its Apoptotic Function at Mitochondria
Eric Lau et al.
CELL (2012)
Lipid-based Nanoparticle Delivery of Pre-miR-107 Inhibits the Tumorigenicity of Head and Neck Squamous Cell Carcinoma
Longzhu Piao et al.
MOLECULAR THERAPY (2012)
Targeting Mcl-1 for the therapy of cancer
Bridget A. Quinn et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
Ganta Vijay Chaitanya et al.
CELL COMMUNICATION AND SIGNALING (2010)
Phenotype and Genotype of Pancreatic Cancer Cell Lines
Emily L. Deer et al.
PANCREAS (2010)
FGF-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the FGF pathway
Wenchao Zhou et al.
CELL RESEARCH (2009)
Share Paper
